Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
MacroGenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
MacroGenics Inc, Medical Devices Deals, 2012 to YTD 2018 10
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
MacroGenics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Mirae Asset Global Investments Acquires 5% Stake in MacroGenics 12
Partnerships 13
MacroGenics Enters into Agreement with Merck 13
MacroGenics Enters into Co-Development Agreement with Takeda Pharma 14
Takeda Pharma Enters Option Agreement with MacroGenics for MGD010 15
Licensing Agreements 17
Provention Bio Enters into Licensing Agreement with MacroGenics for PRV-3279 17
Roche Enters into Licensing Agreement with MacroGenics 18
Incyte Enters into Licensing Agreement with MacroGenics 19
MacroGenics Enters into Licensing Agreement with Synthon Biopharma 20
Janssen Biotech Enters into Licensing Agreement with MacroGenics for MGD015 21
MacroGenics Exercised Option For Licensing Agreement With Servier For DART Products 22
MacroGenics Enters Into Licensing Agreement With Gilead Sciences For DART Technology 24
Equity Offering 26
MacroGenics Raises USD110 Million in Public Offering of Shares 26
Macrogenics Plans to Raise up to USD75 Million in Public Offering of Shares 28
Macrogenics Raises USD23.7 Million in Private Placement of Shares 29
MacroGenics Raises USD150 Million in Public Offering of Shares 30
MacroGenics Raises USD75 Million in Private Placement of Common Stock 32
MacroGenics Completes Public Offering Of Shares For US$82 Million 34
MacroGenics Completes IPO For US$92 Million 36
Asset Transactions 38
Provention Bio Acquires PRV-031 from MacroGenics 38
MacroGenics Inc – Key Competitors 39
MacroGenics Inc – Key Employees 40
MacroGenics Inc – Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Recent Developments 42
Financial Announcements 42
Nov 07, 2018: MacroGenics provides update on corporate progress and 3rd quarter 2018 financial results 42
Aug 07, 2018: MacroGenics provides update on corporate progress and 2nd quarter 2018 financial results 44
May 07, 2018: MacroGenics Provides Update on Corporate Progress and 1st Quarter 2018 Financial Results 46
Feb 27, 2018: MacroGenics Reports 2017 Financial Results 48
Nov 08, 2017: MacroGenics Provides Update on Corporate Progress and Third Quarter 2017 Financial Results 50
Aug 02, 2017: MacroGenics Provides Update on Corporate Progress and Second Quarter 2017 Financial Results 52
May 03, 2017: MacroGenics Provides Update on Corporate Progress and 1st Quarter 2017 Financial Results 54
Feb 28, 2017: MacroGenics Provides Update on Corporate Progress and 2016 Financial Results 56
Corporate Communications 58
Nov 15, 2017: MacroGenics Names Dr. Jay Siegel to its Board of Directors 58
Jan 25, 2017: MacroGenics Announces Appointments to Board of Directors 59
Product News 60
11/10/2017: MacroGenics To Present Poster on MGD019 at 32nd Annual SITC Meeting 2017 60
09/05/2017: MacroGenics Provides Update on its DART candidate MGD013 61
Product Approvals 62
Sep 05, 2017: MacroGenics Advances Development of its DART candidate MGD014 62
Jan 05, 2017: MacroGenics’ MGD006 Granted Orphan Drug Status for AML by FDA 63
Clinical Trials 64
Nov 10, 2017: MacroGenics Announces Poster Presentations on MGD013 at 32nd Annual SITC Meeting 2017 64
Sep 10, 2017: Phase 1 Data for Flotetuzumab, MacroGenics CD123 x CD3 DART Molecule, Presented at ESMO Congress 2017 65
Jul 17, 2017: Phase 1 Data for Flotetuzumab, MacroGenics CD123 x CD3 DART Molecule, Accepted for Oral Presentation at ESMO Congress 2017 66
Appendix 67
Methodology 67
About GlobalData 67
Contact Us 67
Disclaimer 67
MacroGenics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
MacroGenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
MacroGenics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
MacroGenics Inc, Medical Devices Deals, 2012 to YTD 2018 10
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Mirae Asset Global Investments Acquires 5% Stake in MacroGenics 12
MacroGenics Enters into Agreement with Merck 13
MacroGenics Enters into Co-Development Agreement with Takeda Pharma 14
Takeda Pharma Enters Option Agreement with MacroGenics for MGD010 15
Provention Bio Enters into Licensing Agreement with MacroGenics for PRV-3279 17
Roche Enters into Licensing Agreement with MacroGenics 18
Incyte Enters into Licensing Agreement with MacroGenics 19
MacroGenics Enters into Licensing Agreement with Synthon Biopharma 20
Janssen Biotech Enters into Licensing Agreement with MacroGenics for MGD015 21
MacroGenics Exercised Option For Licensing Agreement With Servier For DART Products 22
MacroGenics Enters Into Licensing Agreement With Gilead Sciences For DART Technology 24
MacroGenics Raises USD110 Million in Public Offering of Shares 26
Macrogenics Plans to Raise up to USD75 Million in Public Offering of Shares 28
Macrogenics Raises USD23.7 Million in Private Placement of Shares 29
MacroGenics Raises USD150 Million in Public Offering of Shares 30
MacroGenics Raises USD75 Million in Private Placement of Common Stock 32
MacroGenics Completes Public Offering Of Shares For US$82 Million 34
MacroGenics Completes IPO For US$92 Million 36
Provention Bio Acquires PRV-031 from MacroGenics 38
MacroGenics Inc, Key Competitors 39
MacroGenics Inc, Key Employees 40
MacroGenics Inc, Other Locations 41
List of Figures
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
MacroGenics Inc, Medical Devices Deals, 2012 to YTD 2018 10
【免責事項】
http://www.globalresearch.jp/disclaimer